Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
ATNM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -1.62%199.190.0%$1686.05m
BIIBBiogen, Inc. 1.28%388.441.7%$1298.22m
SNSSSunesis Pharmaceuticals, Inc. 5.98%12.760.7%$891.97m
NVAXNovavax, Inc. -3.05%174.4179.8%$677.69m
AMGNAmgen, Inc. -0.86%238.681.3%$653.84m
BNTXBioNTech SE -0.83%212.420.0%$524.93m
VRTXVertex Pharmaceuticals, Inc. -0.27%187.851.9%$517.31m
GILDGilead Sciences, Inc. -0.91%66.611.0%$493.35m
REGNRegeneron Pharmaceuticals, Inc. 0.36%537.922.7%$384.81m
ILMNIllumina, Inc. 0.18%456.163.5%$365.16m
ALXNAlexion Pharmaceuticals, Inc. 0.40%180.692.0%$338.92m
OCGNOcugen, Inc. 0.00%6.540.0%$285.39m
EXASEXACT Sciences Corp. -0.30%126.5218.1%$189.07m
TXG10X Genomics, Inc. -2.18%194.430.0%$173.74m
BNGOBionano Genomics, Inc. -3.05%7.620.0%$165.33m

Company Profile

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates (ARCs), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company was founded in 2002 and is headquartered in New York, NY.